This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's Why Tree.com (TREE) is a Strong Momentum Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why You Should Hold on to LendingTree (TREE) for Now
by Zacks Equity Research
A flexible business model and focus on non-mortgage product offerings aid LendingTree (TREE). Yet, high costs and falling insurance segment's revenues are expected to hurt its financials.
Surging Earnings Estimates Signal Upside for Tree.com (TREE) Stock
by Zacks Equity Research
Tree.com (TREE) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Why Tree.com (TREE) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
LendingTree, Inc. (TREE) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Tree.com (TREE) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Why Fast-paced Mover Tree.com (TREE) Is a Great Choice for Value Investors
by Zacks Equity Research
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Tree.com (TREE) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
2 Highly Ranked Stocks to Buy After Massive Earnings Beats
by Shaun Pruitt
Currently belonging to the Zacks Rank #1 (Strong Buy) list, Alpha Metallurgical Resources (AMR) and LendingTree's (TREE) stock look appealing after blasting their fourth quarter earnings expectations this week.
What Makes Tree.com (TREE) a New Strong Buy Stock
by Zacks Equity Research
Tree.com (TREE) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
LendingTree (TREE) Q4 Earnings Beat Estimates, Revenues Fall
by Zacks Equity Research
Lower costs support LendingTree's (TREE) Q4 earnings to some extent. However, the overall decline in revenues hurt the company.
New Strong Buy Stocks for February 28th
by Zacks Equity Research
RITM, PPC, TREE, LNW and IAS have been added to the Zacks Rank #1 (Strong Buy) List on February 28, 2023.
Best Value Stocks to Buy for February 28th
by Zacks Equity Research
PPC, RITM and TREE made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 28, 2023.
Compared to Estimates, Tree.com (TREE) Q4 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Tree.com (TREE) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
3 Top-Rated Stocks to Consider as Earnings Approach
by Shaun Pruitt
With representation from a variety of sectors, several top-rated Zacks stocks look attractive ahead of their quarterly reports on Tuesday, February 27.
Curious about Tree.com (TREE) Q4 Performance? Explore Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Tree.com (TREE), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.
Despite Fast-paced Momentum, Tree.com (TREE) Is Still a Bargain Stock
by Zacks Equity Research
Tree.com (TREE) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
The Zacks Analyst Blog Highlights Amphastar Pharmaceuticals, Abercrombie & Fitch, Cameco, CyberArk Software and LendingTree
by Zacks Equity Research
Amphastar Pharmaceuticals, Abercrombie & Fitch, Cameco, CyberArk Software and LendingTree are part of the Zacks top Analyst Blog.
5 Top Growth Stocks to Buy as Recession Fears Subside
by Tirthankar Chakraborty
Invest in growth stocks such as Amphastar Pharmaceuticals (AMPH), Abercrombie & Fitch (ANF), Cameco (CCJ), CyberArk Software (CYBR) and LendingTree (TREE) as the U.S. economy defies recession fears.
Things Are Looking Up for These Relative Price Strength Stocks
by Nilanjan Choudhury
PK, TREE, ANF and OC are four stocks with explosive relative price strength.
Tree.com (TREE) Is Attractively Priced Despite Fast-paced Momentum
by Zacks Equity Research
Tree.com (TREE) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Strength Seen in Tree.com (TREE): Can Its 22.1% Jump Turn into More Strength?
by Zacks Equity Research
Tree.com (TREE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Time to Buy OneMain Holdings (OMF) Stock for Higher Highs?
by Shaun Pruitt
OneMain Holdings' (OMF) valuation and lucrative dividend yield remain enticing to income investors with shares hovering near 52-week highs.
3 Mortgage & Related Services Stocks to Watch Amid Ongoing Woes
by Zacks Equity Research
Despite high mortgage rates and low origination volumes, AGM, TREE and OCN are set to hold ground on robust servicing opportunities and a focus on improving operating leverage.
Tree.com (TREE) Up 17.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Tree.com (TREE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why You Should Hold on to LendingTree (TREE) at Present
by Zacks Equity Research
A flexible business model and focus on non-mortgage product offerings aid LendingTree (TREE). Yet, elevated costs and falling insurance segment's revenues are expected to hurt its financials.